Free Submission Public Relations &
Deutsch English

NRT Smoking Cessation Aids in France

France NRT smoking cessation aids market: EUR 125 million industry in 2012

Print article Print article
2014-02-13 00:30:04 - NRT Smoking Cessation Aids in France - a new market research report on

Laboratoires McNeil led the overall France NRT smoking cessation aids market in 2012, accounting for a 39% share of overall value sales. The company´s well-known brand Nicorette has a broad coverage of products, as it is present in almost all categories in NRT smoking cessation aids. Recent innovation, namely the Nicoretteskin 25mg, and the exit of Nicogum in 2009, helped the company to maintain its lead.

Compared with 2011, the overall category saw slightly slower current value growth in 2012. Two main reasons account for this: the high adoption rate of electronic cigarettes – a UTC product in France – as an alternative deterrent to those quitting smoking, and positive acceptance of other products, such as homeopathic (non-consumer health) Tabapass (Laboratoire



Ferrier/Arkopharma) and the newly launched herbal-plus-vitamins product Nicoprive (active ingredients vitamins, saccharose and plant extracts) by Laboratoire DB Pharma.

In addition to the recent price increases of cigarettes, the French health authorities have begun debating the possibility of following Australian legislation in terms of a logo-free/plain packaging policy for cigarette packs. It is very likely that political and fiscal measures taken by the newly elected socialist government will aim to further reduce the consumption of cigarettes in France, thus favouring an increase in demand for NRT smoking cessation aids in the country over the forecast period. NRT smoking cessation aids is expected to increase by a constant value CAGR of 2% over the next five years.

Key Headlines

- In 2012, NRT smoking cessation aids is the fastest growth OTC category in France, seeing overall current value growth of 5% to reach €125 million
- Two consecutive price increases for cigarettes in France, the impetus set by innovative smoking cessation aids and the deteriorating demand for Rx drugs account for this bullish trend
- NRT lozenges sees the fastest growth in 2012, with a 9% increase in current value terms
- Laboratoires McNeil accounts for a 39% share of value sales in 202, and maintains its lead
- Over the next five years, NRT smoking cessation aids is set to continue growing, with a constant value CAGR of 2%

Click for report details: ..

Browse all Consumer Goods Market Research Reports ..

Browse all Consumer Goods Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact